Comparison of hematological inflammatory parameters in patients with exfoliative glaucoma and exfoliative syndrome

Objective: To evaluate the neutrophil / lymphocyte ratio (NLR), platelet / lymphocyte ratio (PLR), and systemic immune inflammation index (SII) in exfoliative glaucoma (XFG) patients with the aim of comparing the findings with those of healthy controls and exfoliative syndrome (XFS) patients. Methods: In this retrospective cross-sectional study included 134 participants, 22 XFG patients, 41 XFS patients and 71 healthy individuals were examined. Peripheral venous sample values including neutrophil, lymphocyte and platelet levels were recorded from the hospital database. Results: Among evaluated hematological parameters, although the NLR values of the subjects with XFG were greater than those of the subjects with XFS, when the relationship between the NLR, PLR and SII parameters of the XFG and XFS groups, adjusted for age and gender, was examined by logistic regression analysis, no significant difference was found between the groups. Multiple linear regressions of the association between the NLR, PLR and SII parameters and the ocular parameters of the XFG and XFS groups revealed no significant relationship between the blood parameters and ocular measurements. Neutrophil / lymphocyte ratio was found to be the most acceptable discriminant parameter when comparing XFG group with the XFS and control groups (AUC [area under curve]=0.678, AUC=0.663, respectively). Platelet / lymphocyte ratio was found to be the best discriminant parameter between the XFS and control groups (AUC=0.605). Conclusion: No significant difference was found between XFG and XFS groups in terms of NLR, PLR and SII parameters. Considering the fact that NLR has the best AUC when comparing XFG and XFS groups, it may be the most acceptable discriminant parameter between XFG and XFS.

Eksfoliatif glokom ve eksfoliatif sendromlu hastalarda hematolojik enflamatuar parametrelerin karşılaştırılması

Amaç: Eksfoliatif glokom (XFG), eksfoliatif sendrom (XFS) hastalarında ve sağlıklı kontrollerde nötrofil / lenfosit oranı (NLO), platelet / lenfosit oranı (PLO) ve sistemik immün enflamasyon indeksini (Sİİ) karşılaştırmak amaçlandı. Metod: Retrospektif kesitsel çalışmamızda 22 XFG’lu, 41 XFS’lu ve 71 sağlıklı bireyden oluşan toplam 134 katılımcı incelendi. Nötrofil, lenfosit ve trombosit düzeylerini içeren periferik venöz örnek değerleri hastane veri tabanından kaydedildi. Bulgular: Değerlendirilen hematolojik parametreler arasında, XFG'lu olguların NLO değerleri XFS'lu olgulardan daha yüksek olmasına rağmen, XFG ve XFS gruplarının NLO, PLO ve Sİİ parametrelerinin yaş ve cinsiyet açısından düzeltilmiş ilişkileri lojistik regresyon analiziyle incelendiğinde gruplar arasında anlamlı farklılık bulunmadı. XFG ve XFS gruplarının NLO, PLO ve Sİİ parametreleri ile oküler parametrelerinin yaş ve cinsiyet açısından düzeltilmiş ilişkileri çoklu doğrusal regresyon analiziyle incelendiğinde her iki grupta da kan parametreleri ile oküler ölçümleri arasında anlamlı ilişki bulunmadı. XFG grubu; XFS ve kontrol grupları ile karşılaştırıldığında, NLO'nın en kabul edilebilir ayırt edici parametre olabileceği bulundu (sırasıyla AUC [area under curve]=0.678, AUC=0.663). Platelet lenfosit oranının, XFS ve kontrol grupları arasında en iyi ayırt edici parametre olabileceği bulundu (AUC=0.605). Sonuç: Nötrofil / lenfosit oranı, PLO ve Sİİ parametreleri açısından XFG ve XFS grupları arasında anlamlı farklılık bulunmadı. Eksfoliatif glokom ve XFS karşılaştırıldığında en iyi AUC’a sahip olan NLO, XFG ve XFS arasında en kabul edilebilir ayırt edici bir parametre olabilir.

PDF

___

1. Serfőző G, Horváth T, Földesi I, Rafael B, von Känel R, Keresztes M. The Monocyte-to-Lymphocyte Ratio Correlates with Psycho-Neuro-Inflammatory Factors in Patients with Stable Coronary Artery Disease. Neuroimmunomodulation. 2016; 23: 67- 74.

2. Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017; 11: S127- S131.

3. Kurtul BE, Kurtul A, Altiaylik Ozer P, Kabatas EU, Ertugrul GT. Serum lipid levels in pseudoexfoliation syndrome. Semin Ophthalmol. 2017; 32: 281-4.

4. Wang Q, Ma J, Jiang Z, Ming L. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018; 37: 4−11.

5. Kurtul BE, Ozer PA. Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review. Int J Ophthalmol. 2019; 12: 1951-8.

6. Lv Y, Zhang S, Liu Z, Tian Y, Liang N, Zhang J. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma. Clin Neurol Neurosurg. 2019; 181: 24- 7.

7. Mirili C, Paydaş S, Yılmaz A, et al. Prognostic Significance of Dynammic Inflammatory Indexes in Cases Renal Cell Canser Treated by Tyrosine Kinase Inhibitor (TKI). Acta Oncologica Turcica. 2019; 52: 372-8.

8. Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population based cohort study. Int J Cancer. 2020; 146: 692-8.

9. Yelgeç NS, Karataş MB, Karabay YC, et al. The Relationship Between Acute Renal Failure After Transcatheter Aortic Valve Replacement and Preprocedural Neutrophil To Lymphocyte Ratio. Dicle Med J. 2020; 7: 1-9.

10. Türkyılmaz K, Öner V, Kırbas A, et al. Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome. Eye. 2013; 27: 854-9.

11. Ozgonul C, Sertoglu E, Mumcuoglu T, Ozge G, Gokce G. Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio. Ocul Immunol Inflamm. 2016; 24: 665-70.

12. Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Novel Biomarkers of Primary Open-Angle Glaucoma. J Glaucoma. 2016; 25: e815-e820.

13. Kurtul BE, Ozer PA, Kabatas EU. Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome. Eye (Lond). 2016; 30: 1045-8.

14. Arıkan S, Erşan İ, Kara S, et al. Neutrophil Lymphocyte Ratio in Different Types of Glaucoma. Glokom Katarakt. 2016; 11: 221-4.

15. Yüksel N, Mutlu M. Kuru Göz Hastalarında Nötrofil Lenfosit Oranının Oküler Yüzey Bulguları ile İlişkisi. MN Oftalmololoji. 2016; 23: 196-9.

16. Li S, Cao W, Han J, Tang B, Sun X. The diagnostic value of white blood cell, neutrophil, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with primary angle closure glaucoma. Oncotarget. 2017; 8: 68984-95.

17. Atalay K, Kaldirim Erdogan H, Kirgiz A, Asik Nacaroglu S. Predictive role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in normal-tension glaucoma. Med Hypotheses. 2017; 103: 54-6.

18. Dikkaya F, Karaman Erdur S, Ozsutcu M, Aydin R, Kocabora MS, Aras Cl. The significance of neutrophil-to-lymphocyte ratio in idiopathic epiretinal membrane. Int Ophthalmol. 2018; 38: 1393-7.

19. Zhang A, Ning L, Han J, et al. Neutrophil-To-Lymphocyte Ratio as a Potential Biomarker of Neovascular Glaucoma. Ocul Immunol Inflamm. 2019: 1-8.

20. Atalay K, Erdogan Kaldirim H, Kirgiz A, Asik Nacaroglu S. Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Normal Tension Glaucoma. Med Hypothesis Discov Innov Ophthalmol. 2019; 8: 278-82.

21. Mirza E, Oltulu R, Katipoğlu Z, Mirza GD, Özkağnıcı A. Monocyte/HDL Ratio and Lymphocyte/Monocyte Ratio in Patients with Pseudoexfoliation Syndrome. Ocul Immunol Inflamm. 2020; 28: 142-6.

22. Tang B, Li S, Han J, Cao W, Sun X. Associations between Blood Cell Profiles and Primary Open Angle Glaucoma: A Retrospective Case-Control Study. Ophthalmic Res. 2020; 63: 413-22.

23. Yildiz Balci S, Turan-Vural E, Turkyilmaz O, Esen F, Aksaray S. Complete blood count parameters and neutrophil-to-lymphocyte ratio values as markers for differentiation between systemic infectious and non-infectious uveitis. Int Ophthalmol. 2020; 40: 3033-41.